ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641174 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641174; 2) Community: the network communities that were significantly associated with the response to NSC 641174; 3) Molecule: the relationships between components within communities and NSC 641174; 4) MDR: the compounds that were significantly associated with the NSC 641174.

NSC Compound Enrichment Correlation
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0252510646170347 -0.18282649
NSC 111533 Methoxycamptothecin 0.0273093708703115 -0.029398889
NSC 2785 Null 0.0273093708703115 -0.13138556
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0273093708703115 0.065969062
NSC 374028 Camptothecin Derivative 0.0273093708703115 -0.17349071
NSC 606498 Camptothecin Derivative 0.0273093708703115 0.023674588
NSC 609699 Topotecan hydrochloride 0.0273093708703115 -0.14329233
NSC 625505 Null 0.0273093708703115 0.2503216
NSC 64111 Null 0.0273093708703115 0.2947456
NSC 644960 Null 0.0273093708703115 -0.043188437
Total:39  Current:21    [First] [Prev] [Next] [Last]